Preclinical (both in vivo and in vitro) and clinical epilepsy studies we conducted, in which nonsteroidal anti-inflammatory drugs (NSAIDs), such as cyclooxygenase-2 (COX-2) selective inhibitors (COXIBs) and nonselective NSAIDs were used to control seizure. This evidence concerns the gene PTGS2 and epilepsy.